Beaumont Financial Advisors, LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1957394
NEEDHAM, MA
Position in ARWR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$834,825
+$192,777 QoQ
Shares Held
10,242
+0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#256
of 497 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Beaumont Financial Advisors, LLC holds $1,598,507 across 3 Biotechnology names. ARWR ranks #1 (52.2% of the industry book) .
All Filings in ARWR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $834,825 | 10,242 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $642,048 | 10,240 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $689,659 | 10,388 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $356,040 | 10,323 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $161,839 | 10,243 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $128,355 | 10,075 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $189,410 | 10,075 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $197,089 | 10,175 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $264,448 | 10,175 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $291,005 | 10,175 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $311,355 | 10,175 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $285,413 | 10,622 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $378,780 | 10,622 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $268,808 | 10,583 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $427,218 | 10,533 | Shares | Sole | 2023-01-25 | |
| No filing history on record for this holder in this stock. | ||||||